Inside the IQM Quantum Computers SPAC Deal: Terms, Risks, Verdict
IQM Quantum Computers is going public through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ), and the deal has already closed with trading beginning July 2, 2026 under IQMX. The setup gives investors a fast path into a capital-hungry quantum hardware story, but the key questions are dilution, execution, and whether the market is paying too much for a still-loss-making business.
IQM Quantum Computers is going public through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ), and the deal has already closed with trading beginning July 2, 2026 under IQMX. The setup gives investors a fast path into a capital-hungry quantum hardware story, but the key questions are dilution, execution, and whether the market is paying too much for a still-loss-making business.
IQM Quantum Computers is a Finland-based full-stack superconducting quantum computing company founded in 2018. It designs, fabricates, and integrates its own quantum processors, control electronics, and software stack, while also using third-party cryogenic systems. The business is built around selling and installing on-premises quantum systems, offering cloud access to its machines, and providing professional services such as training, maintenance, technical support, and co-development projects.
The company says its vertical integration is aimed at customers that need full control and data sovereignty, especially in governmental, scientific, defense, and sensitive industrial use cases. Its product line includes IQM Spark, a five-qubit system for education and research; IQM Radiance, which spans roughly 20 to 150 qubits; and IQM Halocene, a next-generation system designed to scale beyond 150 qubits. IQM also offers cloud access through IQM Resonance and AWS Braket. The company said it had over 400 employees at announcement, and its materials note that four of the world’s ten largest supercomputing centers use IQM systems.
The industry backdrop is still early and uncertain. IQM’s proxy says the quantum market opportunity is based on third-party research that the company has not independently verified, and management warns that alternative technologies could reduce the eventual market. The bull case is that governments, enterprises, and research centers want scalable quantum hardware with on-prem deployment and data sovereignty; the bear case is that the commercial market remains immature and hard to size.
The SPAC Deal
IQM is merging with Real Asset Acquisition Corp., which trades today under Nasdaq ticker RAAQ. The headline valuation in the transaction materials is a pre-money IQM equity value of approximately $1.8 billion. That is the anchor number retail investors should focus on, because the materials reviewed did not separately state a pro forma enterprise value.
The trust account and redemption math matter here. RAAQ reported $177,124,457 in marketable securities held in trust as of December 31, 2025, and the merger agreement cited approximately $172.5 million in trust at signing. At closing, 7,243,253 public shares were redeemed for cash and 10,006,747 public shares converted into IQM shares, so redemption pressure was meaningful even though it did not wipe out the deal. IQM also disclosed a PIPE of approximately $145.5 million, consisting of 14,548,000 existing IQM shares sold at $10.00 per share to institutional and other accredited investors, including certain RAAQ insiders.
Dilution is another key SPAC mechanic here. RAAQ’s sponsor received 5,750,000 Class B founder shares for $25,000, and the over-allotment was exercised in full, so those founder shares were no longer subject to forfeiture. The sponsor also held 3,725,000 private placement warrants before support-agreement forfeitures; it forfeited 1,544,019 of those and retained 2,180,981. The underwriters held 1,725,000 private placement warrants. Public and private warrants were assumed by IQM at closing and became exercisable at $11.50 per share.
This deal is already closed. It was announced February 22, 2026, the F-4 was filed May 14, 2026, the SEC declared it effective June 5, 2026, shareholders approved it on June 25, 2026, and the business combination closed on July 1, 2026. The combined company began trading on Nasdaq on July 2, 2026 under ticker IQMX, with warrants trading as IQMX WS. IQM also said it intended to apply for a dual listing on Nasdaq Helsinki.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
The SPAC route gives IQM faster access to public capital than a traditional IPO and lets it package a large financing stack around a capital-intensive hardware story. That matters for a company building quantum systems, where commercialization, manufacturing, and deployments require meaningful upfront spending and long development cycles.
The transaction also comes with a PIPE and sponsor support, which can help fund growth after closing. In a de-SPAC, the company can present forward-looking projections more freely than in a standard IPO process, and IQM’s materials lean heavily on that flexibility to frame the long-term market opportunity and its path to scale.
Financial Highlights
IQM’s audited 2025 financials show revenue of €31.3 million, up from €16.4 million in 2024. The company’s own transaction deck described 2025 revenue as $36 million, or over €31 million, which is consistent with the audited figure in euro terms. Revenue comes primarily from on-prem system sales, co-development, and professional services, with some cloud usage revenue.
Losses remain substantial. IQM reported a net loss of €54.4 million in 2025 versus €54.1 million in 2024, and it had an accumulated deficit of €232.2 million as of December 31, 2025. The post-closing F-1 said IQM held €309.4 million in cash after closing and that management believed existing resources were sufficient for at least the next 12 months. That is a useful runway marker, but it is still a projection of sufficiency, not proof of self-funding durability.
Risk Factors
The biggest de-SPAC risk is dilution. Public redemptions reduced the trust-funded capital available to the combined company, while the PIPE, sponsor founder shares, and warrant overhang all add to the share count and can pressure per-share economics. Shareholders should watch how much of the original trust actually stayed in the deal and how the warrant structure affects future dilution.
Execution risk is just as important. IQM expects continued losses and needs to scale commercialization, manufacturing, and deployments while competing against other quantum hardware and platform companies. The proxy also warns that the market opportunity is uncertain and based on unverified third-party research, so the long-term addressable market could be smaller than bulls expect. If capital proves insufficient, IQM may need additional financing on unfavorable terms or may have to delay or reduce development.
There is also the usual SPAC-specific risk that the deal could have broken if redemptions were too high, though that did not happen here. The more practical post-close concern is whether the company can convert its technical lead and customer relationships into durable revenue growth without burning through the cash raised in the transaction.
Comparable Public Companies
The closest public comps are IonQ (IONQ), Rigetti Computing (RGTI), D-Wave Quantum (QBTS), and Quantum Computing Inc. (QUBT). These names give investors a read on how the public market is pricing early-stage quantum exposure, even though each company has a different technical approach and business model.
As of the latest market data provided, IonQ traded at $39.52 with a market cap of about $14.53 billion, and Rigetti traded at $15.20 with a market cap of about $5.06 billion. That tells you the public market is willing to assign very large valuations to quantum names despite limited current revenue. IQM’s $1.8 billion pre-money equity valuation sits below the largest listed peers, but the comparison is imperfect because IQM is still in an earlier commercialization phase and is coming public through a de-SPAC rather than a traditional IPO.
For cross-linking, the comp set to track is IONQ, RGTI, QBTS, and QUBT.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
This is a closed de-SPAC, so the real question is no longer whether the deal gets done; it is whether IQM can justify the valuation and convert its technical story into scale. The setup favors investors who want exposure to a quantum hardware company with real systems shipped, a large cash raise, and a clear customer base in sovereign and research markets, but the stock will still trade on execution more than on near-term profits.
What shareholders should watch now is simple: revenue growth, cash burn, and whether the company can keep winning deployments without leaning on more financing. The reason this matters now is that IQM is entering the public market at a time when quantum names already trade on long-dated expectations, so the market will quickly test whether IQMX can keep up with the sector’s valuation premium.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Picture
Want the full picture on IQMX?
Everything we track on IQMX in one place — the TickerSpark Score, price charts, key financials, and our latest coverage.
